These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7837769)
1. Urinary propionylcarnitine analysis for monitoring carnitine supplementation in inherited disorders of propionate metabolism. Sugiyama N; Matsuda I; Wada Y; Narisawa K; Kobayashi M; Kidouchi K J Inherit Metab Dis; 1994; 17(5):611-5. PubMed ID: 7837769 [No Abstract] [Full Text] [Related]
2. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Di Donato S; Rimoldi M; Garavaglia B; Uziel G Clin Chim Acta; 1984 May; 139(1):13-21. PubMed ID: 6723070 [TBL] [Abstract][Full Text] [Related]
3. Carnitine reduces fasting ketogenesis in patients with disorders of propionate metabolism. Wolff JA; Carroll JE; Le Phuc Thuy ; Prodanos C; Haas R; Nyhan WL Lancet; 1986 Feb; 1(8476):289-91. PubMed ID: 2868163 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation. Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551 [TBL] [Abstract][Full Text] [Related]
5. Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation. Duran M; Ketting D; Beckeringh TE; Leupold D; Wadman SK J Inherit Metab Dis; 1986; 9(2):202-7. PubMed ID: 3091925 [TBL] [Abstract][Full Text] [Related]
6. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia. Böhles H; Lehnert W Eur J Pediatr; 1984 Nov; 143(1):61-3. PubMed ID: 6510434 [TBL] [Abstract][Full Text] [Related]
7. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. Roe CR; Millington DS; Maltby DA; Bohan TP; Hoppel CL J Clin Invest; 1984 Jun; 73(6):1785-8. PubMed ID: 6725560 [TBL] [Abstract][Full Text] [Related]
8. Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism. Burns SP; Iles RA; Saudubray JM; Chalmers RA Eur J Pediatr; 1996 Jan; 155(1):31-5. PubMed ID: 8750807 [TBL] [Abstract][Full Text] [Related]
9. Carnitine deficiency in inherited organic acid disorders and Reye syndrome. Sugiyama N; Kidouchi K; Kobayashi M; Wada Y Acta Paediatr Jpn; 1990 Aug; 32(4):410-6. PubMed ID: 2288224 [TBL] [Abstract][Full Text] [Related]
10. Renal handling of free and acylcarnitine in secondary carnitine deficiency. Ohtani Y; Nishiyama S; Matsuda I Neurology; 1984 Jul; 34(7):977-9. PubMed ID: 6539878 [TBL] [Abstract][Full Text] [Related]
11. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines. Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558 [TBL] [Abstract][Full Text] [Related]
12. Effect of carnitine on propionate metabolism in the vitamin B-12--deficient rat. Brass EP; Ruff LJ J Nutr; 1989 Aug; 119(8):1196-202. PubMed ID: 2778544 [TBL] [Abstract][Full Text] [Related]
13. Interactions of propionate and carnitine metabolism in isolated rat hepatocytes. Brass EP; Beyerinck RA Metabolism; 1987 Aug; 36(8):781-7. PubMed ID: 3110541 [TBL] [Abstract][Full Text] [Related]
15. Carnitine therapy and metabolism in the disorders of propionyl-CoA metabolism studied using 1H-NMR spectroscopy. Davies SE; Iles RA; Stacey TE; de Sousa C; Chalmers RA Clin Chim Acta; 1991 Dec; 204(1-3):263-77. PubMed ID: 1819469 [TBL] [Abstract][Full Text] [Related]
16. Six years' experience with carnitine supplementation in a patient with an inherited defective carnitine transport system. Christensen E; Vikre-Jørgensen J J Inherit Metab Dis; 1995; 18(2):233-6. PubMed ID: 7564256 [No Abstract] [Full Text] [Related]
17. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002 [TBL] [Abstract][Full Text] [Related]
18. Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation. Ribas GS; Manfredini V; de Mari JF; Wayhs CY; Vanzin CS; Biancini GB; Sitta A; Deon M; Wajner M; Vargas CR Int J Dev Neurosci; 2010 Apr; 28(2):127-32. PubMed ID: 20100562 [TBL] [Abstract][Full Text] [Related]
19. Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation. Fontaine M; Briand G; Vallée L; Ricart G; Degand P; Divry P; Vianey-Saban C; Vamecq J Clin Chim Acta; 1996 Aug; 252(2):109-22. PubMed ID: 8853559 [TBL] [Abstract][Full Text] [Related]
20. L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study. Lee PJ; Harrison EL; Jones MG; Jones S; Leonard JV; Chalmers RA J Inherit Metab Dis; 2005; 28(2):141-52. PubMed ID: 15877203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]